Figure 5From: Model-based parametric study of frontostriatal abnormalities in schizophrenia patients Differences of the normalized glutamatergic synaptic efficacy and the PFC activity between schizophrenia patients and healthy subjects (i.e., those in SZ - those in HC), which are given by Eq. ( 11 ), in Model 2.Back to article page